Gilead Sciences earnings: $1.84 per share, ex-items, on revenue of $6.04B

Analysts had expected the company to report earnings of $1.92 a share on $5.99 billion in revenue, according to a consensus estimate from Thomson Reuters.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.